首页> 外文期刊>Experimental Physiology >Interaction of N N ‐acetyl‐seryl‐aspartyl‐lysyl‐proline with the angiotensin‐converting enzyme?2–angiotensin‐(1–7)–Mas axis attenuates pulmonary fibrosis in silicotic rats
【24h】

Interaction of N N ‐acetyl‐seryl‐aspartyl‐lysyl‐proline with the angiotensin‐converting enzyme?2–angiotensin‐(1–7)–Mas axis attenuates pulmonary fibrosis in silicotic rats

机译:n N-乙酰基 - 甲醇 - α-丙氨酸与血管紧张素转化酶α的相互作用 - 血管紧张素 - (1-7)-MAS轴衰减硅藻大鼠的肺纤维化

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

New Findings What is the central question of this study? What are the effects of the antifibrotic peptide acetyl‐seryl‐aspartyl‐lysyl‐proline (Ac‐SDKP) on the angiotensin‐converting enzyme?2 (ACE2)–angiotensin‐(1–7)–Mas axis during the occurrence and progression of silicosis? What is the main finding and its importance? Ac‐SDKP inhibited lung fibrosis in rats exposed to silica by activation of the ACE2–angiotensin‐(1–7)–Mas axis. Angiotensin‐(1–7) potentially promotes Ac‐SDKP by increasing the level of meprin?α, the major synthetase of Ac‐SDKP. Thus, the interaction Ac‐SDKP and angiotesin‐(1–7) in silicosis could provide a new therapeutic strategy. Abstract The central role of angiotensin‐converting enzyme (ACE) in the occurrence and progression of silicosis has been established. The antifibrotic peptide acetyl‐seryl‐aspartyl‐lysyl‐proline (Ac‐SDKP) can be degraded by ACE. The ACE2–angiotensin‐(1–7)–Mas axis is protective and acts to counterbalance the detrimental effects of ACE–angiotensin?II (Ang?II)–Ang?II type?1 receptor and exerts antifibrotic effects. Here, we demonstrate an interaction between Ac‐SDKP and Ang‐(1–7) in the inhibition of collagen deposition and myofibroblast differentiation in rats exposed to silica. Treatment with Ac‐SDKP increased the level of ACE2–Ang‐(1–7)–Mas in rats or in cultured fibroblasts and decreased the levels of collagen type?I and α‐smooth muscle actin. Furthermore, exogenous Ang‐(1–7) had similar antifibrotic effects and increased the level of meprin?α, a major Ac‐SDKP synthetase, both in vivo and in vitro . Compared with non‐silicotic patients exposed to silica, the level of serum ACE was increased in patients with silicosis phase?III; the levels of Ang?II and Ang‐(1–7) were high in patients with silicosis phase?II; and the level of Ac‐SDKP was high in the silicosis phase?III group. These data imply that Ac‐SDKP and Ang‐(1–7) have an interactive effect as regulatory peptides of the renin–angiotensin system and exert antifibrotic effects.
机译:新发现这项研究的核心问题是什么?抗灰肽乙酰乙酰甲醇 - 丙氨酸(AC-SDKP)对血管紧张素转换酶α2(ACE2) - angiotensin-(1-7)-MAS轴的影响是什么?矽肺病?主要发现和重要性是什么? AC-SDKP通过激活ACE2-血管紧张素(1-7)-MAS轴线暴露于二氧化硅的大鼠肺纤维化。血管紧张素 - (1-7)通过增加MEPRINαα,AC-SDKP的主要合成酶来促进AC-SDKP。因此,矽肺中的相互作用AC-SDKP和血管生素 - (1-7)可以提供新的治疗策略。摘要建立了血管紧张素转换酶(ACE)在矽肺病发生和进展中的作用。抗纤维肽乙酰基 - 甲醇 - 丙氨酸 - 脯氨酸(AC-SDKP)可以通过ACE降解。 ACE2-血管紧张素 - (1-7)-MAS轴是保护性的,并使ACE-血管紧张素αII(AngαII)-angα1受体的不利影响抵消抗衡效应并施加抗纤维化效应。这里,我们证明了AC-SDKP和Ang-(1-7)之间的相互作用在暴露于二氧化硅的大鼠中抑制胶原沉积和肌纤维细胞分化。用AC-SDKP治疗增加了大鼠的ACE2-Ang-(1-7)-MAS的水平,或者在培养的成纤维细胞中增加,并降低了胶原蛋白型的水平和α-平滑肌肌动蛋白。此外,外源性Ang-(1-7)具有相似的抗纤维化效应,并增加了体内和体外的主要AC-SDKP合成酶Meprinαααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααααain的水平。与暴露于二氧化硅的非硅藻患者相比,矽肺阶段患者的血清ACE水平ΔIII;矽肺阶段患者患者II和Ang-(1-7)的Ang?II和Ang-(1-7)的水平;矽肺阶段的AC-SDKP水平高,矽肺阶段βIII组。这些数据意味着AC-SDKP和Ang-(1-7)具有作为肾素 - 血管紧张素系统的调节肽的交互效果,并施加抗纤维化效应。

著录项

  • 来源
    《Experimental Physiology》 |2019年第10期|共13页
  • 作者单位

    Basic Medical CollegeHebei Medical UniversityShijiazhuang Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    School of Public HealthNorth China University of Science and TechnologyTangshan Hebei China;

    Foreign Languages CollegeNorth China University of Science and TechnologyTangshan Hebei China;

    Foreign Languages CollegeNorth China University of Science and TechnologyTangshan Hebei China;

    Traditional Chinese Medicine CollegeNorth China University of Science and TechnologyTangshan Hebei;

    School of Public HealthNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    School of Public HealthNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    Medical Research CenterNorth China University of Science and TechnologyTangshan Hebei China;

    Basic Medical CollegeHebei Medical UniversityShijiazhuang Hebei China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 人体生理学;
  • 关键词

    Ac‐SDKP; angiotensin?II; angiotensin‐converting enzyme?2; renin–angiotensin system; silicosis;

    机译:AC-SDKP;血管紧张素?II;血管紧张素转换酶?2;肾素 - 血管紧张素系统;矽肺病;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号